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Several neurodegenerative diseases like Huntington’s, a polyglutamine (PolyQ) disease, are initiated 
by protein aggregation in neurons. Furthermore, these diseases are also associated with a multitude 
of responses in non-neuronal cells in the brain, in particular glial cells, like astrocytes. These non-
neuronal responses have repeatedly been suggested to play a disease-modulating role, but how 
these may be exploited to delay the progression of neurodegeneration has remained unclear. 
Interestingly, one of the molecular changes that astrocytes undergo includes the upregulation of 
certain Heat Shock Proteins (HSPs) that are classically considered to maintain protein homeostasis, 
thus resulting in cell autonomous protection. Previously, we discovered DNAJB6, a member of the 
human DNAJ family, as potent cell autonomous suppressor of PolyQ aggregation and related 
neurodegeneration. In the Chapter 4, we confirmed that the cell autonomous protective function of 
human DNAJB6 against PolyQ aggregation was also maintained in D. melanogaster. In this Chapter, 
using the same cell type specific expression systems in D. melanogaster, we show that exclusive 
expression of DNAJB6 in astrocytes (that do not express PolyQ protein) can delay 
neurodegeneration and expands lifespan when the PolyQ protein is exclusively expressed in 
neurons (that do not co-express DNAJB6 themselves). This provides direct evidence for a non-cell 
autonomous protective role of astrocytes in PolyQ diseases.  
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1. Introduction  
 
Several neurodegenerative diseases (NDs), including Huntington’s disease (HD), are characterized 
by protein aggregation in brain cells and this is thought to initiate or drive their pathology and 
degeneration (Kakkar et al., 2014; Kampinga and Bergink, 2016). Heat Shock Proteins (HSPs), which 
are fundamental regulators of the Protein Quality Control (PQC) system (Hartl et al., 2011), are 
considered to be protective against the aggregation of disease-related proteins and thereby capable 
to delay the onset of NDs (Hageman et al., 2011; Vos et al., 2010; Hageman et al., 2010; Kakkar et 
al., 2016a). In previous studies from our group, we identified DNAJB6, a human HSP of the DNAJ 
family and HSP70 co-chaperone, as a very potent and cell autonomous inhibitor of protein 
aggregation in different in vitro and in vivo models of Polyglutamine (PolyQ) diseases (Hageman et 
al., 2011; Kakkar et al., 2016b), including Huntington’s disease (HD, OMIM:#143100), which is 
characterized by the aggregation of mutant PolyQ Huntingtin (HTT).  
 
In the study described in the Chapter 4, we showed that human DNAJB6 provides cell 
autonomous protection against the toxicity of PolyQ proteins (PolyQ-HTT for HD, and PolyQ-ATXN3 
for SCA3) in D. melanogaster. Notably, the HD model used in this study (and described in the 
previous Chapters) exclusively express PolyQ-HTT and DNAJB6 in the same neurons in the fly brain. 
In line with our previous findings, we confirmed that the DNAJB6 cell autonomous protection is 
associated with a reduction in the PolyQ-HTT aggregate load in fly brains. 
 
In addition to protein aggregation, a common hallmark of nearly all aggregation-related NDs is 
the reactivity of astrocytes, a specific type of glial cells that normally contributes to the brain 
homeostasis and supports the neuronal functions (Sofroniew and Vinters, 2010). The astrocytic 
response during aggregation-related NDs is found in degenerating areas of the brain and is 
characterized by a spectrum of progressive molecular, cellular and functional changes (Sofroniew 
and Vinters, 2010; Ben Haim et al., 2015), which are most likely a response triggered by the neuronal 
damage. On one hand, the (early) astrocytic response has repeatedly been suggested to serve in a 
protective manner to counteract the progression of neurodegeneration. On the other hand, 
(chronic) astrocytic reactivity has also been suggested to be a maladaptive response that leads to 
disease aggravation (Sofroniew, 2009).  
 
Interestingly, one of the molecular changes detected in astrocytes in human brains affected by 
neurodegeneration includes the up-regulation of certain HSPs (Durrenberger et al., 2009; Seidel et 
al., 2012; Wilhelmus et al., 2006; Dabir et al., 2004 and Chapter 2), including DNAJB6 (Durrenberger 
et al., 2009). However, the functional implications of HSPs-up-regulations for the progression of 
neuronal degeneration have not yet been established.  
 
To fully explore whether and how the expression of HSPs in astrocytes contributes to 
neuroprotection in NDs, we generated D.melanogaster lines that exclusively express PolyQ-HTT in 
neurons whilst co-expressing human DNAJB6 in astrocytes to study non-cell autonomous effects. As 




specific combination of parental lines carrying cell-specific promoters and transgenes that allow the 
selective expression of PolyQ-HTT and DNAJB6 respectively in neurons and glial cells/astrocytes in 
the fly brain (Chapter 3). Different combination of these parental lines have been used to also 
generate the experimental flies used in the study presented in the previous Chapter. 
 
Strikingly, the exclusive expression of DNAJB6 in astrocytes provides non-cell autonomous 
protection against progressive neuronal degeneration and prolongs organismal lifespan, although 
not accompanied by a reduction in the PolyQ-HTT aggregate load in the fly brains (therefore 
differently from what observed when the chaperone is expressed together with PolyQ-HTT in the 
same neurons). Rather, under these conditions, in flies that express DNAJB6 in astrocytes, a high 
fraction of astrocytes now contain neuronal derived PolyQ-HTT aggregates, in line with the 
suggestion that astrocytes might take up prion-like PolyQ-HTT aggregates species, a capacity that is 
enhanced by DNAJB6 expression (Brundin et al., 2010; Costanzo and Zurzolo, 2013; Ren et al., 2009; 
Babcock et al., 2015).  
 




UAS/LexO vectors were obtained by cloning the sequences of HttQ100-mRFP (Prof. T. Littleton 
Group, MIT) or V5-DNAJB6 (isoform B) or eGFP (Clontech) in the multiple cloning site of pUAS attB 
or pLexO attB (Prof. K. Basler Group, UZH). Driver (Promoter cell-specific expression) vectors were 
obtained starting from the backbone of plasmids pDPP-Gal4 attB or pDPP-LG attB or pDPP-LhG attB 
(Prof. K. Basler Group, UZH). DPP promoter was substituted with the sequence of promoter elav 
(pan-neuronal, from pElav-Casper vector, Prof. Liqun Luo, Stanford University), repo (pan-glial, from 
pENTRY-D-TOPO-Repo4.3 vector, Prof. C. Klämbt, University of Münster) or alrm (astrocytic, from 
pAlrm-Casper vector, Prof. M. Freeman, UMASS). All obtained vectors were sequenced. See table 
T1 of Chapter 3 for vectors list.  
 
Generation of new D. melanogaster lines 
 
The D. melanogaster lines of table T1 were obtained by injection and transformation of embryos 
with the above mentioned attB vectors, based on attP-site specific PhiC31 integrase system, by Best 
Gene Inc. injection service (https://www.thebestgene.com/HomePage.do). D. melanogaster lines 
from Bloomington Drosophila Stock Center were also used: gmr-Gal4 (Line BDSC #1104 in Fig.3); 
alrm-Gal4 (Line BDSC #67031 in Fig.3); UAS-mCD8-GFP (Line BDSC #5130); UAS-mCD8-RFP (Line 
BDSC #27391); UAS-ATXN3-Q78 (Line BDSC #8150 in Fig.3); gmr-QF2 (Line BDSC #59283 in Fig.3 was 
a gift from C. Potter, Baltimore, MD, U.S.A.). gmr-QF2 and QUAS-ATXN3-Q78 are based on the Q 
expression system in D.melanogaster (Potter et al., 2010). All the lines were isogenised to remove 
background mutations by backcrossing each of them for 6 generations with the control stock w1118 
line. See Chapter 3 for other details. 
 






 Fig. 1A and 1B: w(-); UAS mCD8-RFP(or UAS HttQ100-mRFP) / alrm LhG; elav Gal4 / LexO 
eGFP.  
 Fig. 3: for non-cell autonomous rescue: w(-),gmr-QF2; alrm-Gal4:QUAS ATXN3-Q78/ UAS 
DNAJB6 (or +); +/+.  
 Fig. 5A and S3A: 1) control line (red): w(-); UAS HttQ100-mRFP / promoter(repo or alrm) LhG; 
elav Gal4 / LexO eGFP. 2) Rescued line (blue): w(-); UAS HttQ100-mRFP / promoter (repo or 
alrm) LhG; elav Gal4 / LexO DNAJB6.  
 Fig.7A and S4B: 1) Control (Fig. 7A, panel 1 and Fig. S4B, panels 1-3): w(-); UAS CD8-mRFP / 
alrm LhG; elav Gal4 / LexO eGFP. 2) Condition 1 (Fig. 7A, panel 2 and Fig. S4B, panels 4-6): 
w(-); UAS HttQ100-mRFP / alrm LhG; elav Gal4 / LexO eGFP. 3) Condition 2 (Fig. 7A, panel 3 
and Fig. S4B, panels 7-9).   
 Fig.7B and Movie M1): w(-); UAS HttQ100-mRFP / alrm LhG; elav Gal4 / LexO DNAJB6.     
 Fig. 8A and S5A: 1) Control line (red): w(-); UAS HttQ100-mRFP / alrm LhG; elav Gal4 / LexO 
eGFP. 2) Rescued line (blue): w(-); UAS HttQ100-mRFP / alrm LhG; elav Gal4 / LexO DNAJB6. 
 
Antibodies and reagents 
 
Antibodies (dilutions are indicated in brackets for western blots (WB) and immunofluorescence (IF)) 
against huntingtin (Chemicon, MAB2166, WB 1:5000), eGFP (Clontech-Living Colours, 
cat.No.632375, WB 1:5000), α-tubulin (Sigma Aldrich, clone DM1A, WB 1:2000), V5 epitope tag in 
DNAJB6b (Thermo Fisher Scientific, cat. No.R960-25, WB 1:2000, IF 1:50), NC-82 (DSHB, WB 1:5000) 
were used. DAPI for nuclei staining (cat.No.D1306) was from Thermo Fisher Scientific. 20% SDS 
Solution (cat.No.1610418) was from BioRad. PBS components (NaCl cat.No.S9888, KCl 
cat.No.P9541, Na2HPO4 cat.No.255793, KH2PO4 cat.No.V000225), Tween-20 (cat.No.P2287), 
Triton X-100 (cat.No.T8787), Bovine Serum Albumin (cat.No.A2058, BSA), glycerol (cat.No.G5516), 
3.7% Formaldehyde (cat.No.11-0705 SAJ), Tris base (cat.No.T1503) and β-mercaptoethanol 
(cat.No.M6250) were from Sigma Aldrich. 
 
D. melanogaster stocks maintenance 
 
All stocks and experimental flies were kept in polystyrene vials 25x95 mm filled with 8 ml/vial of 
solidified media (17 g/l Agar; 26 g/l Yeast; 54 g/l Sugar; 1.3 mg/l Nipagin). All experimental flies were 
maintained in a humidified and temperature controlled incubator at 25 °C on a 12 hours’ light and 
12 hours’ dark cycle (Premium ICH Insect Chamber, Snijders Labs). Experimental flies, anesthetized 




Parental flies (5-6 females and 5-6 males) were kept in vial for 3 days and then removed. Offspring 




gender and phenotype were collected and kept in new vials (10 flies/vial). Flies were transferred to 
new vials containing fresh medium every 2 days and deaths were scored daily. Statistical significance 
of curves differences analysed with Log rank (Mantel-Cox) test (test 1) and Gehan-Breslow-Wilcoxon 
test (test 2) using Graph Pad Prism Software Version 5.00. All curves comparisons were made from 
flies analysed in the same experiment. T50 was defined as the time point at which 50% of the initial 
population has died.  
 
Western Blotting D. melanogaster total head lysates preparation 
 
30-40 D. melanogaster adults with specific phenotype, gender, age (days after pupal eclosion) and 
condition were collected; after freezing in liquid nitrogen and vortexing of entire flies, separated 
heads were collected, counted and lysed in SDS-rich buffer (SDS 1.45%, Glycerol 20%; Tris Base 0.2 
M. 2.5 µl of buffer/head) using sonication (3 pulses of 50 Watt for 5 seconds). Homogenized lysate 
was then centrifuged at 1000 x g for 3 seconds to separate cuticle debris from supernatant. Proteins 
in supernatant were collected and quantified using spectrophotometry (Implant NanoPhotometer 
UV/Vis). Protein content was equalized. Samples, supplied with β-mercaptoethanol 5% and 
bromophenol blue, were boiled at 99 °C for 5 minutes. Equal amounts of volume were resolved on 
SDS-PAGE. Flies of the same line were collected from different vials and the entire experiment was 
repeated at least 2 times. 
 
Western Blotting and Blot quantification 
 
Following the preparation of samples, proteins were resolved by SDS-PAGE, transferred to 
nitrocellulose membrane and processed for Western Blotting. Primary antibodies (at concentrations 
mentioned above) were prepared in 3% BSA/PBS-Tween 20 0.1%, secondary antibodies at 
concentration 1:5000 (Invitrogen, horse peroxidase conjugated to IGG or IGM) in 5% milk/PBS-
Tween 20 0.1%. For visualization membranes were incubated with Pierce ECL Western Blotting 
substrate (cat. No. 32106) for 2 minutes and visualized using ChemiDoc Touch Imaging System 
(BioRad). Blots have been quantified using Image Lab Version 5.2.1 software (BioRad). 
 
Analysis of eye degeneration at light microscope 
 
For each condition, at least 80 fly eyes were checked. The fraction of the eyes that showed 
degeneration phenotype were calculated as previously (Vos et al., 2010). For each analysed line, 
eyes of at least 40 flies were scored. The results were average of at least three independent 
experiments.  
 
D.melanogaster Immunofluorescence (IF), Imaging and Punctae Quantification 
 
Brains of experimental D. melanogaster adults with specific phenotype, gender, age (days after 
pupal eclosion) and condition were dissected by light microscope visualization, in 0.1% Triton X-100 
PBS 1x buffer and then fixed in 3.7% Formaldehyde, 0.1% Triton X-100 PBS 1x buffer for 20 minutes 
at room temperature. Staining of brains was performed by blocking not specific sites using 2% BSA, 




0.1% Triton X-100 PBS 1x buffer for 30 minutes at room temperature, then incubating with primary 
antibody (dilution 1:50) in blocking buffer for 2 days at 4°C and finally with secondary Alexa-
conjugated dyes antibody (Invitrogen, Alexa Fluor 488 goat-anti-mouse; dilution 1:500) and DAPI 
(final concentration 0.2 µg/µl) in blocking buffer for 2 days at 4°C, to respectively visualize primary 
antibodies and nuclei. Brains were mounted between glass slide and coverslip, embedded in 
mountant solution (CitiFluor, Agar Scientific) and visualized by confocal microscopy within 24 hours. 
IF images of D.melanogaster brains were captured using confocal laser scanning microscope (Leica 
TCS SP8). Z-stack images were obtained to check for the punctae in cells at different Z-planes. 
Quantification of the punctae in cells was carried out manually. Photoshop, and Image J software 
were used for image processing and to generate the 3D reconstruction (Movie M1). Statistical 





Astrocytes are generally considered to be more resistant to PolyQ-HTT aggregation and toxicity than 
neurons (Jansen et al., 2014; Jansen et al., 2016) and hence PolyQ diseases are primarily thought to 
be due to neuronal dysfunction and death. Moreover, although chronic astrocyte reactivity is 
considered to be detrimental, the initial astrocytic responses have been suggested to actually 
counteract the progression of neurodegeneration. However, direct evidence to substantiate this 
hypothesis is lacking. Importantly, altered expression of several HSPs in astrocytes are amongst such 
molecular changes (Durrenberger et al., 2009; Seidel et al., 2012; Wilhelmus et al., 2006; Dabir et 
al., 2004, and Chapter 2), the relevance of which has not been demonstrated so far.  
 
In order to test whether and how the expression of HSPs in astrocytes might be relevant for the 
non-cell autonomous neuroprotection in PolyQ diseases, we used D.melanogaster as in vivo model 
of HD, and expressed DNAJB6 in glia/astrocytes (the same short nuclear and cytosolic isoform B 
used in the experiments of the previous Chapter; Hanai et al., 2003) to verify its protective activity 
against the toxicity mediated by the expression of HttQ100-mRFP in neurons (the same human 
PolyQ-HTT exons 1-12 construct used in the previous Chapter; Weiss et al., 2012). To do so, we used, 
also for these experiments, the GAL4-UAS (Brand and Perrimon, 1993) and LexA-LexO (Yagi et al., 
2010) expression systems that can drive expression of transgenes in a completely independent and 
non-overlapping manner. 
 
Astrocytes have been suggested to play a key role in many aggregate-related NDs, including HD 
(Sofroniew and Vinters, 2010; Ben Haim et al., 2015). On the one hand, it has been suggested that 
the neuronal damage leads to astrocyte reactivity, which compromises their functions in nourishing 
and protecting neurons. On the other hand, data from rodent HD models and indirect evidence 
derived from human HD brains (Jansen et al., 2016) suggested that PolyQ-HTT may also be directly 
toxic to astrocytes, thus contributing to their chronic reactivity and to a neurodegenerative 
phenotype. In line with these findings and those from rodent models expressing PolyQ-HTT in 
astrocytes (Shin et al., 2005; Bradford et al., 2009), we observed that the selective expression of 




astrocyte-specific alrm-Gal4 promoter; Doherty et al., 2009) reduced the lifespan of the cohort (Fig. 
S1A-B).  
 
In the previous Chapter, we established that the neuronal cell-autonomous protection of human 
DNAJB6 is recapitulated in the D.melanogaster system. Here we addressed whether the up-
regulation of chaperones, like DNAJB6, in astrocytes might non-cell autonomously protect neurons 
against PolyQ mediated degeneration. To test this hypothesis, we selectively expressed DNAJB6 in 
astrocytes (using the specific promoter alrm-LexA; Doherty et al., 2009), or in all glial cells (using the 
pan-glial promoter repo-LexA; Xiong et al., 1994), in the flies co-expressing HttQ100-mRFP in 
neurons (using the validated and well-characterized pan-neuronal promoter elav-Gal4 (Yao et al., 
1993). Fig. 1 and Chapter 3).  
 
Whereas PolyQ-HTT is ubiquitously expressed in HD human brains and rodent models of HD like 
R6/2 mice, in our fly model the PolyQ protein, HttQ100-mRFP, is exclusively expressed in neurons, 
but not in astrocytes or glial cells (Fig. 1): this enabled us to exclusively investigate whether 
astrocytic/glial DNAJB6 expression might exert non-cell autonomous protective effects against the 
toxicity mediated by the PolyQ proteins expressed in neurons. The tissue specific-expression via 
each of these promoters was confirmed by confocal microscopic analysis: control brains with mCD8-
RFP in neurons and eGFP in astrocytes show non-overlapping staining as evidenced by diffuse mCD8-
RFP fluorescence in neuronal lobes (e.g. antennal lobes, mushroom bodies), surrounded by a 
network of eGFP-positive astrocytes with ramified processes (Fig. 1A). Staining of brains of flies 
expressing neuronal HttQ100-mRFP was slightly lower. HttQ100-mRFP foci reminiscent of aggregate 
formation, were mainly detected in the neurons (Fig. 1B). 
 





Figure 1: Co-expression of different transgenes in neurons and astrocytes of D.melanogaster brain. A,B) 
Representative confocal images of brains from 15-day-old adult male flies co-expressing transgenes in 
different cell types using the two independent expression systems Gal4-UAS and LexA-LexO: mCD8-RFP (Fig. 
1A) or HttQ100-mRFP (Fig. 1B) in all neurons and eGFP in astrocytes. Neuronal lobes and regions rich of 
HttQ100-mRFP punctae are shown. In the detail of the merged image of Fig. 1A, astrocytes (closed circles) 
with their processes (arrows) are indicated. In the detail of the merged image of Fig. 1B, neurons bodies 
(dashed circles) with HttQ100-mRFP punctae (arrows) and astrocytes (closed circles) are indicated. Scale bar: 
100 µm. Magnification: 20x. Genotypes in Materials and Methods.   
 
Strikingly, the exclusive expression of DNAJB6 in all glial cells significantly expanded the lifespan 
of flies expressing pan-neuronal HttQ100-mRFP, increasing the T50 by 23% (Fig. 2A, Fig. S2A, E). In 
fact, the exclusive expression of DNAJB6 in astrocytes only resulted in a similar lifespan extension in 
flies expressing pan-neuronal HttQ100-mRFP (by 25%; Fig. 2B, Fig. S2B, E), indicating that the 
expression of DNAJB6 in this specific type of glial cells alone suffices to provide non-cell autonomous 
protection against PolyQ mediated toxicity. The lifespan extension in these lines is also not as 
pronounced as observed when DNAJB6 is expressed in neurons (in which T50 is increased by 43%; 
Fig. 4A, Fig. S2A, S2C of Chapter 4), suggesting that the pro-survival mechanisms mediated by 
DNAJB6 expression in different cell types might be mechanistically distinct and not completely equal 
in terms of effectiveness. Similar to what we found for exclusive DNAJB6 expression in neurons, 
DNAJB6 expression in all glial cells (Fig. S2C, E) or astrocytes (Fig. S2D, E) did not affect lifespan in 
control flies, indicating its specific effect on HttQ100-mRFP related toxicity. 
 
We also found that both glial or astrocytic expression of DNAJB6 at lower levels than those in the 




respectively, instead of repo-LHG or alrm-LHG; Yagi et al., 2010), did not lead to a non-cell 
autonomous protection in terms of lifespan in the pan-neuronal HttQ100-mRFP D. melanogaster 
model (Fig. S2F, S2G and S2J for glial DNAJB6; Fig.S2H, S2I and S2J for astrocytic DNAJB6). These 
data suggest that, similarly to what we observe for the cell autonomous protection by neuronal 
DNAJB6, also the DNAJB6-mediated non-cell autonomous protection depends on the level of the 
expression of the protective chaperone.  
 
 
Figure 2: Effects of glial or astrocytic DNAJB6 expression on lifespan in a pan-neuronal HttQ100-mRFP D. 
melanogaster model.  A, B) Lifespan of isogenised male flies co-expressing neuronal (N>) HttQ100-mRFP with 
either glial (G>) DNAJB6 or eGFP (Fig. 2A) or astrocytic (A>) DNAJB6 or eGFP (Fig.2B). Lifespan of DNAJB6-
expressing line (blue curve) is significantly expanded compared to the control line (red curve) both for Fig.2A 
and Fig.2B. Additional control lines, comparisons, statistics and genotypes are provided in Fig. S2A, B and E. 
 
In a similar approach, we also found that DNAJB6 expression in astrocytes alleviated the level of 
eye degeneration caused by expression of ataxin-3 (ATXN3-Q78) in fly ommatidia (Fig. 3), in a 
different set of experiments. This truncated ATXN3 carries an expanded PolyQ (Q78) (Warrick et al., 
1998), responsible for spinocerebellar ataxia type 3 (SCA-3; OMIM:#109150) (Costa and Paulson, 
2012). Interestingly, whereas the neuronal expression of DNAJB6 leads to a near to complete eye 
protection in the same SCA-3 D. melanogaster model (Fig.2, Chapter 4), the expression of DNAJB6 
in astrocytes does not suffice to prevent depigmentation, but did attenuate progression into 
necrosis (Fig.3A). 
 





Figure 3: Non-cell autonomous protective activity of DNAJB6 against PolyQ-ATXN3 mediated degeneration 
in D. melanogaster ommatidia.  A) Top panels show representative images of eyes of 1-day old adult female 
flies expressing the indicated transgene. Eye degeneration is quantified as the percentage of eyes showing 
either depigmentation (mild degeneration) or black necrotic spots (dotted line, arrowhead) (severe 
degeneration). Data are compared using an unpaired t test (SD; **: P ≤ 0,01. ***: P ≤ 0,001). Genotypes in 
Materials and Methods. 
In order to investigate the mechanism underlying this non-cell autonomous protection observed 
in the HD model, we first considered the possibility of intercellular transmission of DNAJB6 from 






Figure 4: Schematic outline of possible intercellular transmission of DNAJB6 from glial cells/astrocytes to 
neurons in which the chaperone would reduce aggregation of PolyQ-HTT. 
 
 For this hypothesis to be true, such a transfer should lead to reduced aggregation of HttQ100-
mRFP, similar to what we observed for the cell-autonomous protection via the expression of DNAJB6 
in neurons (Fig. 4B, Fig. S2D of Chapter 4). However, DNAJB6 expression in all glial cells or astrocytes 
was not associated with a comparable dramatic reduction of HMW HttQ100-mRFP aggregates in 
total head lysates (Fig. 5A, Fig. S3A). These data confirm the specificity of the used expression 
systems. More importantly, these data imply that the intercellular glia-to-neurons transmission of 
DNAJB6 is unlikely the only or the dominant mechanism for the non-cell autonomous protective 
effects of DNAJB6 on the lifespan of neuronal HttQ100-mRFP flies.  





Figure 5: Effect of glial or astrocytic DNAJB6 expression in the pan-neuronal HttQ100-mRFP D. 
melanogaster model on aggregates formation. A) Western Blots of total head lysates of 5 and 15-day-old 
adult female flies co-expressing neuronal (Neur.>) HttQ100-mRFP and glial (Glial>, lines 1-4) or astrocytic 
(Astr.>, lines 5-8) DNAJB6 or eGFP. Anti-huntingtin antibody used for detection of monomers (100 kDa), 
cleaved products (70 kDa), intermediate aggregated species (130-170 kDa) and HMW aggregates (stacking 
gel) of HttQ100-mRFP. Anti-V5 antibody for (V5 tagged) DNAJB6 detection. Anti-GFP antibody for eGFP 
detection. Tubulin was used as loading control. HMW aggregates of HttQ100-mRFP quantification (signal in 
stacking gel normalized on tubulin signal; a.u.: arbitrary units) for each line is shown. Number of fly heads per 
each lysate sample and genotypes in Materials and Methods. An independent repeat of the experiment is 
shown in Fig. S3A. 
 
In view of these results, we next investigated if other additional pro-survival and non-cell 
autonomous mechanisms would take place when DNAJB6 is expressed in astrocytes. It has been 
suggested that PolyQ-HTT aggregates may spread throughout the brain in a prion-like manner 
(Brundin et al., 2010; Costanzo and Zurzolo, 2013; Ren et al., 2009; Babcock et al., 2015) (Fig. 6) and 
that this progressive spread of disease-associated proteins contributes to the progression of the 
neurodegenerative process. In theory, astrocytes might restrict such spreading via actively taking 
up prion-like protein species, a capacity that might be limited by the progressive accumulation of 







Figure 6. Schematic outline of possible spreading of PolyQ-HTT prion-like species, role of astrocytes in up-
take of seeds and the non-cell autonomous protection of neurons through expression of DNAJB6 in 
astrocytes. 
 
 In line with this idea, confocal microscopic analysis of flies co-expressing neuronal HttQ100-
mRFP and astrocytic eGFP, revealed that approximately ~10% of eGFP-expressing astrocytes, 
contained mRFP punctae (Fig. 7A, C; Fig. S4A, S4B). These puncta are reminiscent of protein 
aggregation and under all conditions are qualitatively associated with the relative amounts of 
insoluble proteinaceous material detected in our western analyses. This phenomenon was not due 
to indiscriminate protein transfer, as shown by the absence of mRFP punctae in eGFP astrocytes of 
the control line expressing neuronal non-aggregating membrane-bound mCD8-RFP (Fig. 7A, C; Fig. 
S4A, S4B). These data support the hypothesis that PolyQ HTT aggregates can indeed be transferred 
from neurons to astrocytes. Importantly, the combined expression of neuronal HttQ100-mRFP with 
astrocytic DNAJB6 resulted in a significant increase in the frequency of astrocytes with RFP punctae 
to ~50% (Fig. 7A-C; Fig. S4A, S4B), suggesting that DNAJB6 expression positively influenced the 
capacity of astrocytes of taking up such prion-like species (Fig. 6). 3-D confocal analyses confirmed 
that HttQ100-mRFP aggregates are indeed inside astrocytes (Fig.7B, Movie M1). 





Figure 7: Effect of glial or astrocytic DNAJB6 expression in the pan-neuronal HttQ100-mRFP D. 
melanogaster model on aggregate distribution within the brain and overall neuronal fitness. A) 
Representative confocal images of brains from 15-day-old adult male flies co-expressing neuronal mCD8-RFP 
or HttQ100-mRFP and astrocytic DNAJB6b or eGFP. For each indicated condition, a representative picture of 
the region in central brain indicated in Fig. S4A is shown. In panels 1-3, detailed images are provided showing 
astrocytes (closed circles) and HttQ100-mRFP punctae in astrocytes (arrows), used for the counting in Fig. 7C. 
Anti-V5 antibody and Alexa488 secondary antibody were used for (V5 tagged) DNAJB6 detection. Scale bar: 
25 µm. Magnification: 40x. Genotypes in Materials and Methods. B) Frames from the representative Movie 
M1 (3D confocal image reconstruction) at different time points, showing astrocytes expressing DNAJB6b and 
containing HttQ100-mRFP puncta (arrows) from 15-day-old adult male flies expressing the indicated 
transgenes. Frames show the same cells from different angles. Anti-V5 antibody and Alexa488 secondary 
antibody were used for (V5 tagged) DNAJB6 detection. Magnification: 63x. Genotypes in Materials and 




section of brains from flies of Fig. 7A and S4B (2 brains, 20 sections per condition). Statistical significance 
analysed with 1-way ANOVA test (SEM, ***, p<0,001). 
 
Similarly to the experiments investigating the cell autonomous protection of DNAJB6 (in the 
previous Chapter), to also confirm that the expression of astrocytic DNAJB6 indeed resulted in the 
actual and specific non-cell autonomous protection of neurons, we analysed the level of the 
neuronal marker NC82 (Wagh et al., 2006) in total fly head lysates. As previously explained, the 
expression level of NC82 provides a direct measure of the functional fitness of the neuronal 
population. We found NC82 levels to be strongly decreased in 15-day-old flies solely expressing 
neuronal HttQ100-mRFP (Fig. S4A and S4B of Chapter 4). This NC82-decline was not only alleviated 
in flies co-expressing neuronal DNAJB6 (cell autonomous protection, Fig. 5A, B and S4C, D of Chapter 
4), but also in flies co-expressing DNAJB6 in astrocytes (non-cell autonomous protection, Fig. 8A, B 




Figure 8: Effect of glial or astrocytic DNAJB6 expression in the pan-neuronal HttQ100-mRFP D. 
melanogaster model on overall neuronal fitness. A) Western blots of NC82 from total head lysates of 5 and 
15-day-old adult female flies co-expressing neuronal (Neur.>) HttQ100-mRFP and astrocytic (Astr.>) DNAJB6 
or eGFP. Anti-NC82 antibody for NC82. Tubulin was used as loading control Number of fly heads per each 
lysate sample and genotypes in Materials and Methods. An independent repeat of the experiment is shown 
in Fig. S5A, B. B) Quantification of NC82 of data in Fig. 8A at day 15 (signal normalized on tubulin; a.u.: 
arbitrary units). 
 
Our experimental findings further also support the conclusion that the effects of DNAJB6 driven 
by repo or alrm drivers are not due to cell-autonomous effects of “leaked” neuronal expression; 
indeed, under the latter condition, we should have seen a reduction of HTTQ100-mRFP aggregation, 
which is not the case (Fig.5A, Fig. S3). Additionally, as shown in Fig. S3 of Chapter 4, we found that 
neuronal co-expression of HTTQ100-mRFP with DNAJB6 at lower levels compared to those in the 
experiment of Fig. 4 of Chapter 4 (using for DNAJB6, the weaker promoter elav-LG instead of elav-
LHG respectively; Yagi et al., 2010), did not lead to cell autonomous protection. In this case, we 
could even detect DNAJB6 in Western blots (Fig.S3D). This makes in extremely unlikely that an 
eventual leakage of repo and alrm drivers, causing non-detectable expression of DNAJB6 in neurons, 
can be held responsible for the 24% increase in obtained life span (Fig.2A, B). 
 




4. Discussion  
Our data are a direct demonstration of a long-assumed hypothesis that glial cells, and particular 
astrocytes, might play a modulating role in HD, which as in many other NDs, initially and primarily 
affects neurons. 
 
PolyQ-HTT is expressed in glial cells in the brain of HD patients and animal models (Jansen et al., 
2016). In line with previous data from rodent models (Shin et al., 2005; Bradford et al., 2009), we 
confirmed that PolyQ-Htt exclusively expressed in astrocytes reduces lifespan in D.melanogaster. 
These data thus indicate that astrocytic PolyQ-HTT may contribute to HD pathology and that 
astrocytic damage is generally detrimental to the health of the brain, as notably observed in 
Alexander disease (OMIM:#203450), a genetic neurodegenerative disorder that primarily affects 
astrocytes by a dominant gain-of-function mutation of the GFAP gene (Sofroniew and Vinters, 2010; 
Olabarria and Goldman, 2017). 
 
However, our data revealing neuroprotection by expression of DNAJB6 in astrocytes differ from 
these latter studies (Jansen et al., 2016; Shin et al., 2005; Bradford et al., 2009), as astrocytes in our 
D. melanogaster model do not express PolyQ-HTT. Still, we found that DNAJB6-expressing 
astrocytes provide a non-cell autonomous protective effects against degeneration of neurons 
expressing PolyQ-HTT. Thus, these data for the first time reveal that astrocytes empowered with 
sufficient chaperone activity, provided by DNAJB6, can provide protection against degeneration of 
neurons in HD.  
 
DNAJB6, the chaperone used in this study, has cell-autonomous protective effects as previously 
shown (Kakkar et al., 2016b, Chapter 4 of this Thesis), which are strongly associated with its ability 
to prevent the initiation of PolyQ aggregation by the core-polyQ fragment, irrespective of regions 
flanking the expansion (Hageman et al., 2010; Månsson et al., 2014), for which it is known that they 
can affect the aggregation propensity of the PolyQ-containing protein (Kuiper et al., 2017). Our 
findings for both in vivo PolyQ HTT and PolyQ ATXN3 fly models show that also not only the cell 
autonomous, but also the non-cell autonomous effects of DNAJB6 are generic for PolyQ proteins. 
 
Interestingly, the non-cell autonomous protection evoked by DNAJB6 expression in astrocytes is 
not associated with a reduction in PolyQ-HTT aggregation. Although it has been suggested that 
DNAJs and other HSPs can be transmitted between cells via exosomes (Takeuchi et al., 2015), the 
absence of an effect on total aggregate formation in our study implies that additional mechanisms 
may underlie the DNAJB6-mediated non-cell autonomous protection.  
 
Despite the use of well-established promoters and two independent expression systems, it could 
still be argued that low levels of neuronal DNAJB6, due to an eventual leakage of the repo-LexA and 
alrm-LexA promoters and beyond detection limit of our microscopic analyses, could have been 
responsible for the observed protection evoked by DNAJB6 expression in astrocytes. However, using 
a weaker elav promoter to drive neuronal DNAJB6 expression than those used in the presented data 
(i.e. using the elav-LG instead of the elav-LhG promoter (Chapter 3 of this Thesis and Yagi et al., 




DNAJB6 expression (Fig. S3 of Chapter 4). This implies that is it highly unlikely that the observed 
protection by astrocytic DNAJB6 expression is due to leakage of the repo-LexA and alrm-LexA 
promoters. 
 
This implies that the observed non-cell autonomous protection via astrocytic DNAJB6 expression 
is directly due to an activity of the chaperone in the astrocytes enhancing its fitness and function. 
We hypothesize such may delay the trans-cellular spreading of PolyQ HTT aggregates in the 
D.melanogaster brain. Cellular experiments have indeed demonstrated that PolyQ-HTT aggregates 
can enter cells where they can initiate intracellular seeding (Kakkar et al., 2016b; Ren et al., 2009) 
and can spread between neurons in the D.melanogaster brain (Babcock et al., 2015). Our data show 
that, in the same organismal system, these neuronal PolyQ-HTT aggregates can end up in astrocytes 
in agreement with observations by Pearce and colleagues (Pearce et al., 2015), using axotomised 
neurons. The uptake of neuron-derived aggregates could imply that astrocytes act as a “reservoir” 
for these toxic prion-like species, thereby preventing their neuron-to-neuron spreading in the brain 
and hence delaying the progression of neurodegeneration. The prion-reservoir capacity of 
astrocytes is likely limited by the toxicity of captured aggregates. However, the upregulation of 
chaperones like DNAJB6 may enhance this capacity, which is supported by our data showing that 
the frequency of astrocytes with inclusions is increased in case of DNAJB6 overexpression. This 
provokes the speculation that DNAJB6 can positively influence the prion-reservoir capacity of 
astrocytes and their ability to prevent the spreading of prion-like species in the brain, via its 
protective functions against PolyQ-HTT toxicity (Hageman et al., 2010). The increased prion-
reservoir capacity of astrocytes ultimately results in an improvement of overall neuronal fitness and 
in an increased lifespan of PolyQ-HTT D.melanogaster model (Fig.6).  
 
An alteration in neuroinflammation could be an additional contributor to the enhanced 
neuroprotection due to the DNAJB6 expression in astrocytes, which hereby might promote a more 
neuroprotective or less neurotoxic pathway. Indeed, astrocytic activation has been claimed to have 
both positive and negative effects on the progression of PolyQ diseases (Sofroniew and Vinters, 
2010). 
 
In conclusion, our findings support the hypothesis that increasing astrocyte fitness and functions 
by chaperones like DNAJB6 (tentatively by increasing their prion-reservoir capacity) has protective 
significance in HD and possibly other protein aggregation-related NDs which show a pathology 
associated with these prion-like species such as Alzheimer’s (OMIM:#104300) and Parkinson’s 
(OMIM:#168601) (Brundin et al.,2010; Costanzo and Zurzolo et al., 2013). 
  






 Babcock DT, Ganetzky B (2015) Transcellular spreading of huntingtin aggregates in the Drosophila brain. Proc Natl 
Acad Sci, 112: 5427-33.  
 Ben Haim L, Carrillo-de Sauvage MA, Ceyzériat K, Escartin C (2015) Elusive roles for reactive astrocytes in 
neurodegenerative diseases. Front Cell Neurosci, 9: 1-27.  
 Bradford J, Shin J, Roberts M, Wang CE, Li XJ, Li S (2009) Expression of mutant huntingtin in mouse brain astrocytes 
causes age-dependent neurological symptoms. Proc Natl Acad Sci USA, 106: 22480-22485.  
 Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant 
phenotypes. Development, 118: 401-415. 
 Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. 
Nat Rev Mol Cell Biol, 11: 301-307.  
 Costa C, Paulson HL (2012) Progress in Neurobiology Toward understanding Machado – Joseph disease. Prog 
Neurobiol, 97: 239-257.  
 Costanzo M, Zurzolo C (2013) The cell biology of prion-like spread of protein aggregates: mechanisms and 
implication in neurodegeneration. Biochem J, 452: 1-17. 
 Dabir DV, Trojanowski JQ, Richter-Landsberg C, Lee VM-Y, Forman MS (2004) Expression of the small heat-shock 
protein alphaB-crystallin in tauopathies with glial pathology. Am J Pathol, 164: 155-166. 
 Doherty J, Logan MA, Taşdemir OE, Freeman MR(2009) Ensheathing glia function as phagocytes in the adult 
Drosophila brain. J Neurosci, 29: 4768–4781.  
 Durrenberger PF, Filiou MD, Moran LB, Michael GJ, Novoselov S, Cheetham ME, Clark P, Pearce RK, Graeber MB 
(2009) DnaJB6 is present in the core of Lewy bodies and is highly up-regulated in Parkinsonian astrocytes. J 
Neurosci Res, 87: 238-245.  
 Hageman J, Rujano MA, van Waarde MA, Kakkar V, Dirks RP, Govorukhina N, Oosterveld-Hut HM, Lubsen NH, 
Kampinga HH (2010) A DNAJB Chaperone Subfamily with HDAC-Dependent Activities Suppresses Toxic Protein 
Aggregation. Mol Cell, 37: 355-369.  
 Hageman J, van Waarde MA, Zylicz A, Walerych D, Kampinga HH (2011) The diverse members of the mammalian 
HSP70 machine show distinct chaperone-like activities. Biochem J, 435: 127-142.  
 Hanai R, Mashima K (2003) Characterization of two isoforms of a human DnaJ homologue, HSJ2. Mol Biol Rep, 30: 
149-153.  
 Hartl FU, Bracher A, Hayer-Hartl M (2011) Molecular chaperones in protein folding and proteostasis. Nature, 
475:324-332. 
 Jansen AH, van Hal M, Op den Kelder IC, Meier RT, de Ruiter AA, Schut MH, Smith DL, Grit C, Brouwer N, Kamphuis 
W, et al (2016) Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific. 
Glia, 65: 50-61.  
 Jansen AHP, Reits E A, Hol EM (2014) The ubiquitin proteasome system in glia and its role in neurodegenerative 
diseases. Front Mol Neurosci, 7: 1-14. 
 Kakkar V, Kuiper EFE, Pandey A, Braakman I, Kampinga HH (2016a) Versatile members of the DNAJ family show 
Hsp70 dependent anti-aggregation activity on RING1 mutant parkin C289G. SciRep, 6: 34830. 
 Kakkar V, Månsson C, de Mattos EP, Bergink S, van der Zwaag M, van Waarde MA, Kloosterhuis NJ, Melki R, van 
Cruchten RT, Al-Karadaghi S, et al (2016b) The S/T-Rich Motif in the DNAJB6 Chaperone Delays Polyglutamine 
Aggregation and the Onset of Disease in a Mouse Model. Mol Cell, 62: 272-283.  
 Kakkar V, Meister-Broekema M, Minoia M, Carra S, Kampinga HH (2014) Barcoding heat shock proteins to human 
diseases : looking beyond the heat shock response. Dis Model Mech, 7: 421-434 
 Kampinga HH, Bergink S (2016) Heat shock proteins as potential targets for protective strategies in 
neurodegeneration. Lancet Neurol, 15: 748-759. 
 Kuiper EFE, de Mattos EP, Jardim LB, Kampinga HH, Bergink S (2017) Chaperones in Polyglutamine Aggregation : 
Beyond the Q-Stretch. Front Neurosci, 11: 1-11.  
 Månsson C, Kakkar V, Monsellier E, Sourigues Y, Härmark J, Kampinga HH, Melki R, Emanuelsson C (2014) DNAJB6 
is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at 




 Olabarria M, Goldman JE (2017) Disorders of Astrocytes : Alexander Disease as a Model. Annu Rev Pathol, 12: 131-
152.  
 Pearce MMP, Spartz EJ, Hong W, Luo L, Kopito RR (2015) Prion-like transmission of neuronal huntingtin aggregates 
to phagocytic glia in the Drosophila brain. Nat Commun, 6: 6768.  
 Potter CJ, Tasic B, Russler EV, Liang L, Luo L (2010) The Q System: A Repressible Binary System for Transgene 
Expression, Lineage Tracing, and Mosaic Analysis. Cell, 141: 536-548. 
 Ren P-H, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, Kopito RR (2009) Cytoplasmic penetration and persistent 
infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol, 11: 219-225.  
 Seidel K, Vinet J, Dunnen WFA, Brunt ER, Meister M, Boncoraglio A, Zijlstra MP, Boddeke HW, Rüb U, Kampinga 
HH, Carra S (2012) The HSPB8-BAG3 chaperone complex is upregulated in astrocytes in the human brain affected 
by protein aggregation diseases. Neuropathol Appl Neurobiol, 38: 39-53.  
 Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ (2005) Expression of mutant huntingtin in glial cells contributes to 
neuronal excitotoxicity. J Cell Biol, 171: 1001-1012. 
 Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci, 32: 
638-647.  
 Sofroniew MV, Vinters HV (2010) Astrocytes: Biology and pathology. Acta Neuropathol, 119: 7-35.  
 Takeuchi T, Suzuki M, Fujikake N, Popiel HA, Kikuchi H, Futaki S, Wada K, Nagai Y (2015) Intercellular chaperone 
transmission via exosomes contributes to maintenance of protein homeostasis at the organismal level. Proc Natl 
Acad Sci USA, 112: E2497-2506.  
 Vos MJ, Zijlstra MP, Kanon B, van Waarde-Verhagen MA, Brunt ERP, Oosterveld-Hut HMJ, Carra S, Sibon OC, 
Kampinga HH (2010) HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular 
chaperones. Hum Mol Genet, 19: 4677-4693.  
 Wagh DA, Rasse TM, Asan E, Hofbauer A, Schwenkert I, Dürrbeck H, Buchner S, Dabauvalle MC, Schmidt M, Qin G, 
et al (2006) Bruchpilot, a protein with homology to ELKS/CAST, is required for structural integrity and function of 
synaptic active zones in Drosophila. Neuron, 49: 833-844.  
 Warrick JM, Paulson HL, Gray-Board GL, Bui QT, Fischbeck KH, Pittman RN, Bonini NM (1998) Expanded 
Polyglutamine Protein Forms Nuclear Inclusions and Causes Neural Degeneration in Drosophila. Cell, 93: 939-949.  
 Weiss KR, Kimura Y, Lee WCM, Littleton JT (2012) Huntingtin aggregation kinetics and their pathological role in a 
drosophila Huntington’s disease model. Genetics, 190: 581-600.  
 Wilhelmus MMM, Otte-Höller I, Wesseling P, De Waal RMW, Boelens WC, Verbeek MM (2006) Specific association 
of small heat shock proteins with the pathological hallmarks of Alzheimer’s disease brains. Neuropathol Appl 
Neurobiol, 32: 119-130. 
 Xiong W-C, Hideyuki O, Patel NH, Blendy JA, Montell C (1994) repo encodes a glial-specific homeo domain protein 
required in the Drosophila nervous system. Genes Dev, 8: 981-994. 
 Yagi R, Mayer F, Basler K (2010) Refined LexA transactivators and their use in combination with the Drosophila 
Gal4 system. Proc Natl Acad Sci USA, 107: 16166-16171.  
 Yao KM, Samson ML, Reeves R, White K (1993) Gene elav of Drosophila melanogaster: A prototype for neuronal-















Figure S1. Lifespan analyses of D.melanogaster line expressing PolyQ HTT in astrocytes. A) Lifespan of 
isogenised male expressing HttQ100-mRFP or control transgene (eGFP or only promoter) in all astrocytes. 
Detailed statistics, comparisons and genotypes are shown in Fig.S1B. B) Genotypes of lines, comparisons, and 
statistical analysis of lifespan curves of Fig.S1A. Statistical significance analysed using ≈100 flies/group with 








Figure S2 (A-E). Lifespan analyses of control lines depicted in Fig. 2. A) Lifespan of isogenised male flies 
(additional control lines of Fig. 2A) co-expressing neuronal (N>) HttQ100-mRFP and glial (G>) DNAJB6 or eGFP. 
Detailed statistics, comparisons and genotypes are shown in Fig. S2E.  B) Lifespan of isogenised male flies 
(additional control lines of Fig. 2B) co-expressing neuronal (N>) HttQ100-mRFP and astrocytic (A>) DNAJB6 or 
eGFP. Detailed statistics, comparisons and genotypes are shown in Fig. S2E. C) Lifespan of isogenised male 
flies expressing glial (G>) DNAJB6 or eGFP. Detailed statistics, comparisons and genotypes are shown in Fig. 
S2E. D) Lifespan of isogenised male flies expressing astrocytic (A>) DNAJB6 or eGFP. Detailed statistics, 
comparisons and genotypes are shown in Fig. S2E. E) Genotypes of lines, comparisons, and statistical analysis 
of lifespan curves of: Fig. 2A and S2A; Fig. 2B and S2B; Fig. S3C; Fig. S3D. Statistical significance analysed 
using ≈100 flies/group with Log Rank Mantel-Cox test (Test 1) and Gehan-Breslow-Wilcoxon Test (Test 2). 
 
 






Figure S2 (F-J). Lifespan analyses of lines with moderate expression of glial or astrocytic DNAJB6 
in the pan-neuronal HttQ100-mRFP D. melanogaster model. F) Lifespan of isogenized male flies co-
expressing neuronal (N>) HttQ100-mRFP with glial (G>) DNAJB6 or eGFP. Data shown are for 
moderate expression of LexO-DNAJB6/eGFP using repo-LG promoter. Additional control lines, 
comparisons, statistics and genotypes are provided in Fig.S2G and J. G) Lifespan of isogenized male 
flies (additional control lines of Fig. S2F) co-expressing neuronal (N>) HttQ100-mRFP and glial (G>) 
DNAJB6 or eGFP. Detailed statistics, comparisons and genotypes are shown in Fig.S2J. H) Lifespan of 
isogenized male flies co-expressing neuronal (N>) HttQ100-mRFP with astrocytic (A>) DNAJB6 or 
eGFP. Data shown are for moderate expression of LexO-DNAJB6/eGFP using alrm-LG promoter. 
Additional control lines, comparisons, statistics and genotypes are provided in Fig.S2I and J. I) 
Lifespan of isogenized male flies (additional control lines of Fig. S2H) co-expressing neuronal (N>) 
HttQ100-mRFP and astrocytic (A>) DNAJB6 or eGFP. Detailed statistics, comparisons and genotypes 
are shown in Fig. S2J. J) Genotypes of lines, comparisons, and statistical analysis of lifespan curves 
of Fig. S2F-G and S2H-I. Statistical significance analyzed using ≈100 flies/group with Log rank 







Figure S3. Effect of glial or astrocytic DNAJB6 expression in the pan-neuronal HttQ100-mRFP D. 

















Figure S4. Supplemental experiments to Fig.7. A) Representative confocal image of D. melanogaster brain 
(expressing pan-neuronal mCD8-RFP, via elav), indicating the different neuronal lobes and highlighting the 
central brain region analysed for data of Fig. 7A, S4B, 7B and 7C. B) Representative confocal images of a 
repeat of the experiment shown in Fig.7A. In panels 1-9, detailed images are provided showing neurons 





Figure S5. Supplemental experiments to Fig.8. A) Independent repeat of experiment shown in Fig. 8A, B. I) 




M1) Representative 3D reconstruction from confocal microscopic imaging showing astrocytes expressing 
DNAJB6b (green fluorescence) with HttQ100-mRFP puncta. Sample from 15-day-old adult male flies 
expressing neuronal HttQ100-mRFP and astrocytic DNAJB6b. Anti-V5 antibody and Alexa488 secondary 
antibody were used for (V5 tagged) DNAJB6 detection. DAPI was used for nuclei detection. Magnification: 
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